Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD P 506 A photodynamic therapy for mild to moderate actinic keratosis
2004-001949-15Phase 2Completed
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of 5-aminolevulinic acid in actinic keratosis (AK) (4 arms), sponsored by photonamic GmbH & Co. KG. Primary endpoint: Clinical complete clearance rate at week 8. Started Dec 2004; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2004-001949-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001949-15.